Mannatech, Incorporated

NasdaqCM MTEX

Mannatech, Incorporated EPS (Diluted) for the Trailing 12 Months (TTM) ending September 30, 2024: USD -0.81

Mannatech, Incorporated EPS (Diluted) is USD -0.81 for the Trailing 12 Months (TTM) ending September 30, 2024, a 79.95% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Mannatech, Incorporated EPS (Diluted) for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -4.04, a -278.41% change year over year.
Mannatech, Incorporated EPS (Diluted) for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 2.26, a -40.56% change year over year.
Mannatech, Incorporated EPS (Diluted) for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 3.81, a 17.23% change year over year.
Mannatech, Incorporated EPS (Diluted) for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 3.25, a 1,810.53% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

NasdaqCM: MTEX

Mannatech, Incorporated

CEO	Mr. Landen Granvel Fredrick
IPO Date	Feb. 16, 1999
Location	United States
Headquarters	1410 Lakeside Parkway
Employees	213
Sector	Health Care
Industries Pharmaceuticals Cosmetics

Description

Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.

Key trends

Past 5 years